ERYTHRO-TEVA 500 MG Israel - inglês - Ministry of Health

erythro-teva 500 mg

teva pharmaceutical industries ltd, israel - erythromycin as stearate - tablets - erythromycin as stearate 500 mg - erythromycin - erythromycin - treatment of the following infections when caused by susceptible organisms: upper and lower respiratory tract infections. skin and soft tissue infections. conjunctivitis of the newborn caused by chlamydia trachomatis. urogenital infections caused by chlamydia trachomatis. venereal diseases (as an alternative regimen to penicillins and tetracyclines). intestinal amebiasis. legionnaires' disease. long-term prophylaxis in rheumatic fever. short-term prophylaxis against bacterial endocarditis in patients hypersensitive to penicillin who have congenital heart disease or rheumatic or other acquired valvular heart disease when undergoing dental procedures and surgical procedures of the upper respiratory tract. enteric infections caused by campylobacter jejuni.

TOPIRAMATE TEVA  300 MG Israel - inglês - Ministry of Health

topiramate teva 300 mg

teva pharmaceutical industries ltd, israel - topiramate - tablets - topiramate 300 mg - topiramate - topiramate - topiramate teva is indicated as adjunctive therapy for adults and children from 2 years and above with partial onset seizures or generalized tonic-clonic seizures. topiramate teva is also indicated in adults and children as adjunctive therapy for the treatment of seizures associated with lennox-gastaut syndrome . topiramate teva is indicated as monotherapy in patients with newly diagnosed epilepsy in adults and children aged 7 years and above or for conversion to monotherapy in patients with epilepsy.topiramate teva is indicated in adults for the prevention of migraines. the use of topiramate teva in the acute treatment of migraine has not been studied .

TOPIRAMATE TEVA  300 MG Israel - inglês - Ministry of Health

topiramate teva 300 mg

teva pharmaceutical industries ltd, israel - topiramate - tablets - topiramate 300 mg - topiramate - topiramate - topiramate teva is indicated as adjunctive therapy for adults and children aged 6 and above with partial onset seizures or generalized tonic-clonic seizures. topiramate teva is also indicated in adults and children as adjunctive therapy for the treatment of seizures associated with lennox-gastaut syndrome . topiramate teva is indicated as monotherapy in patients with newly diagnosed epilepsy in adults and children aged 7 years and above or for conversion to monotherapy in patients with epilepsy.

TOPIRAMATE TEVA  400 MG Israel - inglês - Ministry of Health

topiramate teva 400 mg

teva pharmaceutical industries ltd, israel - topiramate - tablets - topiramate 400 mg - topiramate - topiramate - topiramate teva is indicated as adjunctive therapy for adults and children from 2 years and above with partial onset seizures or generalized tonic-clonic seizures. topiramate teva is also indicated in adults and children as adjunctive therapy for the treatment of seizures associated with lennox-gastaut syndrome . topiramate teva is indicated as monotherapy in patients with newly diagnosed epilepsy in adults and children aged 7 years and above or for conversion to monotherapy in patients with epilepsy.topiramate teva is indicated in adults for the prevention of migraines. the use of topiramate teva in the acute treatment of migraine has not been studied .

TOPIRAMATE TEVA  400 MG Israel - inglês - Ministry of Health

topiramate teva 400 mg

teva pharmaceutical industries ltd, israel - topiramate - tablets - topiramate 400 mg - topiramate - topiramate - topiramate teva is indicated as adjunctive therapy for adults and children aged 6 and above with partial onset seizures or generalized tonic-clonic seizures. topiramate teva is also indicated in adults and children as adjunctive therapy for the treatment of seizures associated with lennox-gastaut syndrome . topiramate teva is indicated as monotherapy in patients with newly diagnosed epilepsy in adults and children aged 7 years and above or for conversion to monotherapy in patients with epilepsy.

MIRTAZAPINE TEVA  30 MG Israel - inglês - Ministry of Health

mirtazapine teva 30 mg

teva pharmaceutical industries ltd, israel - mirtazapine - tablets - mirtazapine 30 mg - mirtazapine - mirtazapine - episode of major depression.

MIRTAZAPINE TEVA  30 MG Israel - inglês - Ministry of Health

mirtazapine teva 30 mg

teva pharmaceutical industries ltd, israel - mirtazapine - tablets - mirtazapine 30 mg - mirtazapine - mirtazapine - episode of major depression.

MIRTAZAPINE TEVA  45 MG Israel - inglês - Ministry of Health

mirtazapine teva 45 mg

teva pharmaceutical industries ltd, israel - mirtazapine - tablets - mirtazapine 45 mg - mirtazapine - mirtazapine - episode of major depression.

MIRTAZAPINE TEVA  45 MG Israel - inglês - Ministry of Health

mirtazapine teva 45 mg

teva pharmaceutical industries ltd, israel - mirtazapine - tablets - mirtazapine 45 mg - mirtazapine - mirtazapine - episode of major depression.

IMATINIB TEVA  100 MG Israel - inglês - Ministry of Health

imatinib teva 100 mg

teva pharmaceutical industries ltd, israel - imatinib as mesylate - film coated tablets - imatinib as mesylate 100 mg - imatinib - for the treatment of adult patients and children 3 years of age and above with ph+ chronic myeloid leukaemia (ph+ -cml) in chronic phase accelerated phase or blast crisis. imatinib teva is also indicated for the treament of : adult patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukemia (ph+ all) integrated with chemotherapy. adult patients with relapsed or refractory ph + all as monotherapy. adult patients with unresectable dermatofibrosarcoma protuberans (dfsp) and adult patients with recurrent and/or metastatic dfsp who are not eligible for surgery. adult patients with myelodyspiastic/myeloproliferative diseases (mds/mpd) associated with pdgfr ( platelet - derived growth factor receptor ) gene re- arrangements. adult patients with hypereosinophilic syndrome (hes) and/or chronic eosinophilic leukaemia (cel) who have the fip1l1- pdgfralfa fusion kinase (mutational analysis or fish demonstration fo chic2 allele deletion) and for patients with hes and/or cel who are fip1l1-p